Skip to main content

Prostatic Health Status Index

  • Chapter

Abstract

A prostatic health status index (PHSI) can serve as a quantitative yardstick for decision-making about costs, money, operative indications, operative results, and the efficacy of drug therapy. We have evolved such an index based on the conventional urological work-up by combining the signs and symptoms and the presence or absence of health for determining the economic implications of benign prostatic hypertrophy (BPH). Cost-effectiveness is the analytical tool most commonly used by economists to measure the efficiency of resource utilization for medical care. Essentially, it asks the question, “Is the money being spent for the best results?”

Keywords

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (Canada)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berg RL (ed.): Health Status Indexes. Hospital Research and Educational Trust, Chicago, 1973

    Google Scholar 

  2. Boyarsky S, Jones G, Paulson DF, Prout GR Jr: A new look at bladder neck obstruction by the Food and Drug Administration regulators: guidelines for the investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg 68: 29–32, 1977

    Google Scholar 

  3. Bunker JP, Barnes BA, Mosteller F: Costs, Risks Saul Boyarsky and Robert S. Woodward and Benefits of Surgery. Oxford University Press, New York, 1977

    Google Scholar 

  4. Castro JE (ed.): The Treatment of Prostatic Hypertrophy and Neoplasia. University Park Press, Baltimore, 1974

    Google Scholar 

  5. Geller J: Medical treatment of benign prostatic hypertrophy. In Castro JE (ed.): The Treatment of Prostatic Hypertrophy and Neoplasia. University Park Press, Baltimore, 1974, pp 27–58

    Google Scholar 

  6. Glenn JF (ed.): Urologie Surgery, 3rd ed. Harper & Row, New York, 1982

    Google Scholar 

  7. Grayhack JT, Sadlowski R: Results of surgical treatment of benign prostatic hyperplasia. In Grayhack JT, Wilson JD, Scherbenske MJ (eds.): Benign Prostatic Hyperplasia. DHEW Pubi. No. (NIH)76–1113, US Gov’t Printing Office, Washington, DC, 1976, pp 125–134

    Google Scholar 

  8. Melchoir J, Valk WL, Foret JD, Mebust WK: Transurethral prostatectomy: computer analysis of 2223 consecutive cases. J Urol 112: 634–642, 1974

    Google Scholar 

  9. Nicoli GA: Suprapubic prostatectomy: a comparative analysis of 525 consecutive cases. J Urol 111: 213–216, 1974

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Boyarsky, S., Woodward, R.S. (1983). Prostatic Health Status Index. In: Hinman, F., Boyarsky, S. (eds) Benign Prostatic Hypertrophy. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5476-8_80

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-5476-8_80

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-5478-2

  • Online ISBN: 978-1-4612-5476-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics